Öner Tulum is a research associate at The Academic-Industry Research Network (theAIRnet) and a visiting scholar at the University of Massachusetts Amherst. He is completing his PhD at the University of Ljubljana where his current research efforts concentrate on the examination of the prevailing productivity crisis in the U.S. biopharmaceutical industry and the impacts of the financialization of the high-tech economy on the development and sustainability of organizational capabilities.
By this expert
Price gouging in the US pharmaceutical drug industry goes back more than three decades.
Why are we paying for corporate behavior that crushes innovation, cheats taxpayers, cost jobs, and heightens inequality?